Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chroma Medicine
Biotech
CRISPR Tx, Novartis, Cour & more—Chutes & Ladders
CRISPR Tx plucks Sanofi leader for CMO spot. Novartis taps leader for newly created innovation role. Cour finds permanent CMO in Acelyrin alum.
Gabrielle Masson
,
Andrea Park
May 24, 2024 8:30am
Epigenetic silencing lasts in mice, Chroma-sponsored study shows
Feb 28, 2024 11:00am
Hepatitis B drug developers chart slow progress, just like hep C
Nov 14, 2023 9:05am
Chroma bags $135M to bolster epigenetic-focused platform
Feb 28, 2023 6:10pm
After Chroma and Prime, Newpath lines up $350M for 8-12 biotechs
Dec 8, 2021 6:00am
Music to its ears: Tune bags $40M to alter gene expression
Dec 2, 2021 6:00am
